Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02591628 · ClinicalTrials.gov registry record · NA
Treatment of Hypertension In Adults With ThiaZIDES: Pragmatic Trial Pilot Study
A NA study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 2,027
- Enrollment target
NCT02591628 is a NA study that has completed, run by HealthPartners Institute. The registered enrollment target is 2,027 participants.
The verdict
NCT02591628, a NA study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,027 participants
- Enrollment target
Study Summary
This proposed pilot study will test methods and feasibility for a large pragmatic clinical trial comparing two inexpensive, first-line drugs for treating high blood pressure to determine if one is superior in preventing serious cardiovascular events and death. It will develop and test novel approaches to conducting trials that will be faster, less expensive, and more realistic by being embedded in a typical practice setting and using advanced health information technology.
Interventions
- BEHAVIORAL HCTZ prescription conversion to chlorthalidone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,027 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02591628
The ClinicalTrials.gov registry entry for NCT02591628 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,027 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HCTZ prescription conversion to chlorthalidone is the first listed.
NCT02591628 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02591628 about?
NCT02591628 is a clinical study titled "Treatment of Hypertension In Adults With ThiaZIDES: Pragmatic Trial Pilot Study". This proposed pilot study will test methods and feasibility for a large pragmatic clinical trial comparing two inexpensive, first-line drugs for treating high blood pressure to determine if one is superior in preventing serious cardiovascular events and death. It will develop and test novel approach...
What is the current status of trial NCT02591628?
This trial is currently completed. It is a NA study. The enrollment target is 2,027 participants. The study started on 2015-08. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02591628?
The interventions under investigation include: HCTZ prescription conversion to chlorthalidone (BEHAVIORAL).
Who is sponsoring clinical trial NCT02591628?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.